A GLP-1 microdosing schedule involves taking smaller-than-standard doses, which may be used under provider supervision to help manage tolerability
Weight Loss Plateau on Semaglutide Semaglutide (Wegovy) produces an average of 14.9% body weight loss at 68 weeks on the 2.4mg maximum dose, per the STEP 1 trial (Wilding et al., NEJM 2021)
A professional weight loss provider takes a deep look at your medical history, current health status, and lifestyle before designing a treatment plan that complements Retatrutide therapy
Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P
If the difference is dramatic, a light blush versus a dark red, contact the pharmacy to confirm batch consistency
Additionally, it has been found that excess oxidation of the cell causes the skin to become itchy, itchy, flaky and dark beneath the skin